GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $19,975,000 | +48.7% | 835,773 | -9.2% | 0.00% | +33.3% |
| Q4 2020 | $13,434,000 | -1.7% | 920,200 | -4.4% | 0.00% | 0.0% |
| Q3 2020 | $13,664,000 | -5.4% | 962,254 | -2.0% | 0.00% | 0.0% |
| Q2 2020 | $14,446,000 | +370.7% | 982,089 | +31.9% | 0.00% | +200.0% |
| Q1 2020 | $3,069,000 | -16.0% | 744,808 | -1.9% | 0.00% | 0.0% |
| Q4 2019 | $3,654,000 | -20.4% | 759,592 | +0.3% | 0.00% | 0.0% |
| Q3 2019 | $4,588,000 | +4.6% | 757,206 | +12.0% | 0.00% | 0.0% |
| Q2 2019 | $4,386,000 | -6.9% | 675,830 | +1.7% | 0.00% | 0.0% |
| Q1 2019 | $4,710,000 | +40.4% | 664,300 | -3.7% | 0.00% | 0.0% |
| Q4 2018 | $3,355,000 | -32.9% | 690,110 | +1.4% | 0.00% | 0.0% |
| Q3 2018 | $5,001,000 | +18.3% | 680,325 | +2.6% | 0.00% | 0.0% |
| Q2 2018 | $4,229,000 | +21.5% | 662,837 | +3.5% | 0.00% | 0.0% |
| Q1 2018 | $3,482,000 | +19.5% | 640,145 | -8.4% | 0.00% | 0.0% |
| Q4 2017 | $2,913,000 | -56.7% | 698,528 | -0.1% | 0.00% | -50.0% |
| Q3 2017 | $6,734,000 | -9.8% | 699,201 | +10.9% | 0.00% | 0.0% |
| Q2 2017 | $7,462,000 | +0.7% | 630,760 | +9.2% | 0.00% | 0.0% |
| Q1 2017 | $7,407,000 | +7.0% | 577,776 | +2.1% | 0.00% | 0.0% |
| Q4 2016 | $6,925,000 | +17.9% | 565,742 | +13.6% | 0.00% | 0.0% |
| Q3 2016 | $5,875,000 | +35.2% | 497,878 | -0.3% | 0.00% | +100.0% |
| Q2 2016 | $4,345,000 | +68.1% | 499,387 | +2.4% | 0.00% | 0.0% |
| Q1 2016 | $2,585,000 | -30.2% | 487,617 | +2.2% | 0.00% | 0.0% |
| Q4 2015 | $3,701,000 | -0.1% | 476,950 | +1.3% | 0.00% | 0.0% |
| Q3 2015 | $3,706,000 | -10.9% | 470,904 | +2.6% | 0.00% | 0.0% |
| Q2 2015 | $4,160,000 | -29.7% | 459,165 | +0.7% | 0.00% | -50.0% |
| Q1 2015 | $5,920,000 | -4.6% | 456,072 | +0.0% | 0.00% | 0.0% |
| Q4 2014 | $6,205,000 | +48.8% | 455,979 | -1.9% | 0.00% | +100.0% |
| Q3 2014 | $4,170,000 | -29.7% | 464,874 | +6.0% | 0.00% | -50.0% |
| Q2 2014 | $5,935,000 | +27.7% | 438,630 | -6.2% | 0.00% | +100.0% |
| Q1 2014 | $4,647,000 | -31.7% | 467,569 | -8.7% | 0.00% | -50.0% |
| Q4 2013 | $6,803,000 | +14.5% | 511,847 | +4.5% | 0.00% | 0.0% |
| Q3 2013 | $5,944,000 | +301.6% | 489,633 | +242.2% | 0.00% | +100.0% |
| Q2 2013 | $1,480,000 | – | 143,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,500,000 | $25,725,000 | 3.13% |
| CADIAN CAPITAL MANAGEMENT, LP | 3,830,399 | $28,153,000 | 1.28% |
| Mesirow Financial Investment Management, Inc. | 33,001 | $243,000 | 1.25% |
| Bellevue Group AG | 1,339,502 | $9,845,000 | 0.62% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 260,000 | $1,912,000 | 0.58% |
| Lyon Street Capital, LLC | 109,850 | $807,000 | 0.50% |
| Private Wealth Partners, LLC | 300,000 | $2,205,000 | 0.34% |
| Penn Capital Management Company, LLC | 455,064 | $3,345,000 | 0.25% |
| HighTower Advisors, LLC | 2,337,132 | $17,179,000 | 0.12% |
| Schonfeld Strategic Advisors LLC | 376,000 | $2,763,000 | 0.12% |